This report includes an in-depth study of the Asia-Pacific genetic testing market (henceforth, referred to as the ‘market studied’). A genetic test is a test performed to identify the presence of a particular gene/s with a particular sequence of the genome. The gene/s can be identified either directly through sequencing or indirectly through various methods. Genetic testing practices are rapidly increasing in rare disease diagnostics and for personal medicines, which in turn is fuelling the growth of this market. Market size provided in the report has been derived from the revenue generated by products. For estimating the market size of the product, the average selling price (ASP) of a product in the region has been multiplied with the sales volume (new sales and replacement rate, based on applicability). The genetic testing market is segmented by type, disease, technology, and geography. By type, the segmentation includes Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Prenatal Testing, and Other Diseases. By Disease, the segmentation involves Alzheimer’s Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Rare Diseases, and Other Diseases. By technology it includes Cytogenetic Testing, Biochemical Testing, and Molecular Testing. Geographically, the market studied is segmented into Asia-Pacific. And Asia-Pacific has been divided further into major countries, for which market size and forecast value are provided separately. Other countries in that particular region are covered under the “Rest of that region”, for which the market size and forecast value are provided as a whole.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW AND INDUSTRY TRENDS

6. MARKET DYNAMICS

7. MARKET SEGMENTATION

8. COMPANY PROFILES AND COMPETITIVE LANDSCAPE

9. FUTURE OF THE MARKET